News

Patients with age-related macular degeneration patients who had received anti-platelet derived growth factor (PDGF) therapy prior to anti-VEGF treatment fared better than those who did not in a pilot study.

If asked to balance the desires of athletes eager to compete after years of training and the host country's desire to conduct the games as scheduled versus the public health risk of the Zika virus and Aedes aegypti duo, what would you advise?

By 2020, there will be over 5,200 gigabytes of data available for every individual worldwide, she said.Ophthalmology seems ready for Big Data as evidenced by the findings dating back to the 1990s.

Ophthalmologists spend significant amounts of time during cataract surgery trying to precisely center an implanted IOL to achieve the best possible vision after surgery. The high success rate of cataract surgery suggests that in most cases, they succeed.

Physicians have the option of various adjunctive therapy when prostaglandin analog therapy alone is not sufficiently potent to lower IOP, i.e., they can add one agent, a fixed-combination therapy, or perform selective laser trabeculoplasty (SLT).

Similar to their smartphone counterparts, smartwatch applications allow physicians to view schedules, basic patient information, and communicate with ancillary staff.

In this installment of Sight Lines, J.C. Noreika, MD, MBA, talks with Thomas Ebner, MD, a community-based surgeon from Medina, OH, who, in his retirement after a fulfilling career of more than 30 years, brings his expertise, care, and compassion to the underserved of Kenya. Though Dr. Ebner’s expertise is in general orthopedic practice, his passion for volunteerism is universal among many professionals in the greater medical community, including ophthalmology. Dr. Ebner shares the challenges and insights he has gained in his second career.

Implantation of two second-generation trabecular micro-bypass stents (iStent inject, Glaukos) as a single procedure or combined with cataract surgery is a safe and effective option for reducing IOP and the medication burden in eyes with open-angle glaucoma and IOP uncontrolled by medication and/or surgery, according to German surgeons.

High-level evidence supports the use of anti-vascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration (AMD), but falls short of recommending any one agent over another in terms of efficacy or safety, said Paul Sternberg Jr., MD.

In a phase IIa study of patients with neovascular age-related macular degeneration, a single subretinal injection of rAAV.sFlt-1 gene therapy demonstrated acceptable safety, but not a complete or durable anti-VEGF response. Additional preclinical research is under way.

People-like my neighbor and I-for centuries, have tended to give too much weight to negative news stories and gloomy predictions. Hence my resolution for 2016 to pay less attention to the doomsayers and pour more drinks for my friends.

Squalamine lactate-when combined with ranibizumab for treating neovascular age-related macular degeneration-achieved improved visual function when compared with the results achieved with ranibizumab treatment alone.